+1 347 708 0418
Report Summary
Anti-epileptic Drugs for Pediatrics-Global Market Status and Trend Report 2015-2026 offers a comprehensive analysis on Anti-epileptic Drugs for Pediatrics industry, standing on the readers perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Anti-epileptic Drugs for Pediatrics 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Anti-epileptic Drugs for Pediatrics worldwide, with company and product introduction, position in the Anti-epileptic Drugs for Pediatrics market
Market status and development trend of Anti-epileptic Drugs for Pediatrics by types and applications
Cost and profit status of Anti-epileptic Drugs for Pediatrics, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Anti-epileptic Drugs for Pediatrics market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Anti-epileptic Drugs for Pediatrics industry.
The report segments the global Anti-epileptic Drugs for Pediatrics market as:
Global Anti-epileptic Drugs for Pediatrics Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Anti-epileptic Drugs for Pediatrics Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
1st Generation
2nd Generation
3rd Generation
Global Anti-epileptic Drugs for Pediatrics Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Hospitals
Retail Pharmacies
Online Pharmacies
Global Anti-epileptic Drugs for Pediatrics Market: Manufacturers Segment Analysis (Company and Product introduction, Anti-epileptic Drugs for Pediatrics Sales Volume, Revenue, Price and Gross Margin):
Mylan N.V
UCB Pharma Limited
Janssen Pharmaceuticals
Cephalon, Inc
Sanofi S.A
GlaxoSmithKline plc
Valeant Pharmaceuticals International, Inc
Pfizer, Inc
Novartis AG
Sunovion Pharmaceuticals Limited
Zogenix
Zynerba
GW Pharmaceuticals
Insys
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
Chapter 1 Overview of Anti-epileptic Drugs for Pediatrics
1.1 Definition of Anti-epileptic Drugs for Pediatrics in This Report
1.2 Commercial Types of Anti-epileptic Drugs for Pediatrics
1.2.1 1st Generation
1.2.2 2nd Generation
1.2.3 3rd Generation
1.3 Downstream Application of Anti-epileptic Drugs for Pediatrics
1.3.1 Hospitals
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Anti-epileptic Drugs for Pediatrics
1.5 Market Status and Trend of Anti-epileptic Drugs for Pediatrics 2015-2026
1.5.1 Global Anti-epileptic Drugs for Pediatrics Market Status and Trend 2015-2026
1.5.2 Regional Anti-epileptic Drugs for Pediatrics Market Status and Trend 2015-2026
Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Anti-epileptic Drugs for Pediatrics 2015-2019
2.2 Production Market of Anti-epileptic Drugs for Pediatrics by Regions
2.2.1 Production Volume of Anti-epileptic Drugs for Pediatrics by Regions
2.2.2 Production Value of Anti-epileptic Drugs for Pediatrics by Regions
2.3 Demand Market of Anti-epileptic Drugs for Pediatrics by Regions
2.4 Production and Demand Status of Anti-epileptic Drugs for Pediatrics by Regions
2.4.1 Production and Demand Status of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
2.4.2 Import and Export Status of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Chapter 3 Global Market Status and Forecast by Types
3.1 Production Volume of Anti-epileptic Drugs for Pediatrics by Types
3.2 Production Value of Anti-epileptic Drugs for Pediatrics by Types
3.3 Market Forecast of Anti-epileptic Drugs for Pediatrics by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Anti-epileptic Drugs for Pediatrics by Downstream Industry
4.2 Market Forecast of Anti-epileptic Drugs for Pediatrics by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Anti-epileptic Drugs for Pediatrics
5.1 Global Economy Situation and Trend Overview
5.2 Anti-epileptic Drugs for Pediatrics Downstream Industry Situation and Trend Overview
Chapter 6 Anti-epileptic Drugs for Pediatrics Market Competition Status by Major Manufacturers
6.1 Production Volume of Anti-epileptic Drugs for Pediatrics by Major Manufacturers
6.2 Production Value of Anti-epileptic Drugs for Pediatrics by Major Manufacturers
6.3 Basic Information of Anti-epileptic Drugs for Pediatrics by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Anti-epileptic Drugs for Pediatrics Major Manufacturer
6.3.2 Employees and Revenue Level of Anti-epileptic Drugs for Pediatrics Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Anti-epileptic Drugs for Pediatrics Major Manufacturers Introduction and Market Data
7.1 Mylan N.V
7.1.1 Company profile
7.1.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.1.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Mylan N.V
7.2 UCB Pharma Limited
7.2.1 Company profile
7.2.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.2.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of UCB Pharma Limited
7.3 Janssen Pharmaceuticals
7.3.1 Company profile
7.3.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.3.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Janssen Pharmaceuticals
7.4 Cephalon, Inc
7.4.1 Company profile
7.4.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.4.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Cephalon, Inc
7.5 Sanofi S.A
7.5.1 Company profile
7.5.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.5.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Sanofi S.A
7.6 GlaxoSmithKline plc
7.6.1 Company profile
7.6.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.6.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of GlaxoSmithKline plc
7.7 Valeant Pharmaceuticals International, Inc
7.7.1 Company profile
7.7.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.7.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International, Inc
7.8 Pfizer, Inc
7.8.1 Company profile
7.8.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.8.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Pfizer, Inc
7.9 Novartis AG
7.9.1 Company profile
7.9.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.9.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Novartis AG
7.10 Sunovion Pharmaceuticals Limited
7.10.1 Company profile
7.10.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.10.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Sunovion Pharmaceuticals Limited
7.11 Zogenix
7.11.1 Company profile
7.11.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.11.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Zogenix
7.12 Zynerba
7.12.1 Company profile
7.12.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.12.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Zynerba
7.13 GW Pharmaceuticals
7.13.1 Company profile
7.13.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.13.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of GW Pharmaceuticals
7.14 Insys
7.14.1 Company profile
7.14.2 Representative Anti-epileptic Drugs for Pediatrics Product
7.14.3 Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Insys
Chapter 8 Upstream and Downstream Market Analysis of Anti-epileptic Drugs for Pediatrics
8.1 Industry Chain of Anti-epileptic Drugs for Pediatrics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Anti-epileptic Drugs for Pediatrics
9.1 Cost Structure Analysis of Anti-epileptic Drugs for Pediatrics
9.2 Raw Materials Cost Analysis of Anti-epileptic Drugs for Pediatrics
9.3 Labor Cost Analysis of Anti-epileptic Drugs for Pediatrics
9.4 Manufacturing Expenses Analysis of Anti-epileptic Drugs for Pediatrics
Chapter 10 Marketing Status Analysis of Anti-epileptic Drugs for Pediatrics
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
List of Tables
Table Advantage and Disadvantage of 1st Generation
Table Advantage and Disadvantage of 2nd Generation
Table Advantage and Disadvantage of 3rd Generation
Table Production Volume of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Table Production Value of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Table Demand Volume of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Table Production and Demand Status of Anti-epileptic Drugs for Pediatrics in Region One 2015-2019
Table Production and Demand Status of Anti-epileptic Drugs for Pediatrics in Region Two 2015-2019
Table Production and Demand Status of Anti-epileptic Drugs for Pediatrics in Region Three 2015-2019
Table Production and Demand Status of Anti-epileptic Drugs for Pediatrics in Region Four 2015-2019
Table Import Volume of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Table Export Volume of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Table Production Volume of Anti-epileptic Drugs for Pediatrics by Types 2015-2019
Table Production Value of Anti-epileptic Drugs for Pediatrics by Types 2015-2019
Table Production Volume Forecast of Anti-epileptic Drugs for Pediatrics by Types 2020-2026
Table Production Value Forecast of Anti-epileptic Drugs for Pediatrics by Types 2020-2026
Table Demand Volume of Anti-epileptic Drugs for Pediatrics by Downstream Industry 2015-2019
Table Demand Volume Forecast of Anti-epileptic Drugs for Pediatrics by Downstream Industry 2020-2026
Table Production Volume of Anti-epileptic Drugs for Pediatrics by Major Manufacturers 2015-2019
Table Production Value of Anti-epileptic Drugs for Pediatrics by Major Manufacturers 2015-2019
Table Headquarters Location and Established Time of Anti-epileptic Drugs for Pediatrics Major Manufacturer
Table Employees and Revenue Level of Anti-epileptic Drugs for Pediatrics Major Manufacturer
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Mylan N.V
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Mylan N.V
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Mylan N.V 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of UCB Pharma Limited
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of UCB Pharma Limited
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of UCB Pharma Limited 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Janssen Pharmaceuticals
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Janssen Pharmaceuticals
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Janssen Pharmaceuticals 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Cephalon, Inc
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Cephalon, Inc
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Cephalon, Inc 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Sanofi S.A
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Sanofi S.A
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Sanofi S.A 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of GlaxoSmithKline plc
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of GlaxoSmithKline plc
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of GlaxoSmithKline plc 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Valeant Pharmaceuticals International, Inc
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Valeant Pharmaceuticals International, Inc
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International, Inc 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Pfizer, Inc
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Pfizer, Inc
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Pfizer, Inc 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Novartis AG
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Novartis AG
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Novartis AG 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Sunovion Pharmaceuticals Limited
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Sunovion Pharmaceuticals Limited
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Sunovion Pharmaceuticals Limited 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Zogenix
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Zogenix
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Zogenix 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Zynerba
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Zynerba
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Zynerba 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of GW Pharmaceuticals
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of GW Pharmaceuticals
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of GW Pharmaceuticals 2015-2019
Table Representative Anti-epileptic Drugs for Pediatrics Product One of Insys
Table Representative Anti-epileptic Drugs for Pediatrics Product Two of Insys
Table Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin of Insys 2015-2019
List of Figures
Figure Representative Commercial Product Picture of Anti-epileptic Drugs for Pediatrics
Figure Global Shipments Volume Share of Anti-epileptic Drugs for Pediatrics by Types in 2019
Figure Representative Commercial Product Picture of 1st Generation
Figure Representative Commercial Product Picture of 2nd Generation
Figure Representative Commercial Product Picture of 3rd Generation
Figure Demand Volume Share of Anti-epileptic Drugs for Pediatrics by Downstream Industry in 2019
Figure Hospitals Examples of Anti-epileptic Drugs for Pediatrics
Figure Retail Pharmacies Examples of Anti-epileptic Drugs for Pediatrics
Figure Online Pharmacies Examples of Anti-epileptic Drugs for Pediatrics
Figure Global Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate 2015-2026
Figure Global Anti-epileptic Drugs for Pediatrics Market Size Comparison in 2015, 2019 and 2026
Figure North America Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate 2015-2026
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate 2015-2026
Figure China Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate 2015-2026
Figure Japan Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate 2015-2026
Figure Rest APAC Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate 2015-2026
Figure Latin America Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate 2015-2026
Figure Production Volume and Growth Rate of Anti-epileptic Drugs for Pediatrics 2015-2019
Figure Production Value and Growth Rate of Anti-epileptic Drugs for Pediatrics 2015-2019
Figure Production Volume Share of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Figure Production Volume Share of Anti-epileptic Drugs for Pediatrics by Regions in 2015
Figure Production Volume Share of Anti-epileptic Drugs for Pediatrics by Regions in 2019
Figure Production Volume Growth Rate Comparison of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Figure Production Value Share of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Figure Production Value Share of Anti-epileptic Drugs for Pediatrics by Regions in 2015
Figure Production Value Share of Anti-epileptic Drugs for Pediatrics by Regions in 2019
Figure Production Value Growth Rate Comparison of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Figure Demand Volume Share of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Figure Demand Volume Share of Anti-epileptic Drugs for Pediatrics by Regions in 2015
Figure Demand Volume Share of Anti-epileptic Drugs for Pediatrics by Regions in 2019
Figure Demand Volume Growth Rate Comparison of Anti-epileptic Drugs for Pediatrics by Regions 2015-2019
Figure Production Volume Share of Anti-epileptic Drugs for Pediatrics by Types 2015-2019
Figure Production Volume Share of Anti-epileptic Drugs for Pediatrics by Types in 2015
Figure Production Volume Share of Anti-epileptic Drugs for Pediatrics by Types in 2019
Figure Production Volume Growth Rate Comparison of Anti-epileptic Drugs for Pediatrics by Types 2015-2019
Figure Production Value Share of Anti-epileptic Drugs for Pediatrics by Types 2015-2019
Figure Production Value Share of Anti-epileptic Drugs for Pediatrics by Types in 2015
Figure Production Value Share of Anti-epileptic Drugs for Pediatrics by Types in 2019
Figure Production Value Growth Rate Comparison of Anti-epileptic Drugs for Pediatrics by Types 2015-2019
Figure Production Volume Share Forecast of Anti-epileptic Drugs for Pediatrics by Types in 2026
Figure Production Value Share Forecast of Anti-epileptic Drugs for Pediatrics by Types in 2026
Figure Demand Volume Share of Anti-epileptic Drugs for Pediatrics by Downstream Industry 2015-2019
Figure Demand Volume Share of Anti-epileptic Drugs for Pediatrics by Downstream Industry in 2015
Figure Demand Volume Share of Anti-epileptic Drugs for Pediatrics by Downstream Industry in 2019
Figure Demand Volume Growth Rate Comparison of Anti-epileptic Drugs for Pediatrics by Downstream Industry 2015-2019
Figure Demand Volume Share Forecast of Anti-epileptic Drugs for Pediatrics by Downstream Industry in 2026
Figure Production Volume Share of Anti-epileptic Drugs for Pediatrics by Major Manufacturers in 2015
Figure Production Volume Share of Anti-epileptic Drugs for Pediatrics by Major Manufacturers in 2019
Figure Production Value Share of Anti-epileptic Drugs for Pediatrics by Major Manufacturers in 2015
Figure Production Value Share of Anti-epileptic Drugs for Pediatrics by Major Manufacturers in 2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of Mylan N.V 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of UCB Pharma Limited 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of Janssen Pharmaceuticals 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of Cephalon, Inc 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of Sanofi S.A 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of GlaxoSmithKline plc 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of Valeant Pharmaceuticals International, Inc 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of Pfizer, Inc 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of Novartis AG 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of Sunovion Pharmaceuticals Limited 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of Zogenix 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of Zynerba 2015-2019
Figure Anti-epileptic Drugs for Pediatrics Revenue and Market Share of GW Pharmaceuticals 2015-2019
Buy
